China’s “zero tolerance” approach to COVID-19 outbreaks has led to measures to curb its worst surge since 2020 that will further disrupt global supply chains, The New York Times reported March 15.
The FDA and the medical device industry reached an agreement on key points of the fifth iteration of the Medical Device User Fee Amendments, Politico reported March 11.
The FDA on March 10 issued a notification order to Philips Respironics requiring the company to notify all customers of the company’s June 14 recall of certain Philips Respironics ventilators.
Some patient advocacy groups are voicing concerns that a federal policy blocking Mexican nationals from entering the U.S. to donate plasma could cause shortages of critical drugs used to treat neurological and autoimmune diseases, The Wall Street Journ…